Gain Therapeutics to Participate in the 2023 BTIG Virtual Biotechnology Conference
July 31 2023 - 7:00AM
Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”),
a biotechnology company leading the discovery and development of
allosteric small molecule therapies, today announced that members
of management will participate in a fireside chat at the 2023 BTIG
Virtual Biotechnology Conference on Tuesday, August 8 at 9:30 a.m.
ET and host investor meetings.
To listen to the webcast or schedule meetings
with management, please contact your BTIG representative.
About Gain Therapeutics, Inc.
Gain Therapeutics, Inc. is a biotechnology company leading the
discovery and development of allosteric small molecule therapies.
With its proprietary computational discovery platform SEE-Tx®, Gain
Therapeutics is transforming drug discovery by identifying novel
allosteric targets on proteins involved in diseases across the full
spectrum of therapeutic areas. By binding to allosteric binding
sites, the small molecules discovered with SEE-Tx provide
opportunities for a range of drug-protein interactions, including
protein stabilization, protein destabilization, targeted protein
degradation, allosteric inhibition, and allosteric activation.
Gain’s pipeline spans neurodegenerative diseases, lysosomal storage
disorders (LSDs), metabolic disorders, as well as other diseases
that can be targeted through protein degradation, such as oncology.
Gain’s lead program in Parkinson’s disease has been awarded funding
support from The Michael J. Fox Foundation for Parkinson’s Research
(MJFF) and The Silverstein Foundation for Parkinson’s with GBA, the
Eurostars-2 joint program with co-funding from the European Union
Horizon 2020 research and Innosuisse, and through a Swiss
Accelerator Innovation Project supported by Innosuisse. For more
information, please visit https://www.gaintherapeutics.com
Investor & Media Contact:Argot
Partners(212) 600-1902Gain@argotpartners.com
Gain Therapeutics (NASDAQ:GANX)
Historical Stock Chart
From Apr 2024 to May 2024
Gain Therapeutics (NASDAQ:GANX)
Historical Stock Chart
From May 2023 to May 2024